申聯生物(688098.SH):通過農業農村部獸藥GCP監督檢查
格隆匯4月1日丨申聯生物(688098.SH)公佈,近日通過了農業農村部畜牧獸醫局獸藥臨牀試驗質量管理規範(GCP)的監督檢查。公司本次通過監督檢查並符合獸藥臨牀試驗質量管理規範(GCP)要求的試驗項目信息如下:

獸藥GCP即獸藥臨牀試驗質量管理規範,是為了規範獸藥臨牀試驗過程,確保試驗數據的真實性、完整性和準確性,根據《獸藥管理條例》制定的規範。公司本次通過農業農村部畜牧獸醫局獸藥臨牀試驗質量管理規範(GCP)的監督檢查項目共4個,標誌着公司繼具備開展獸用生物製品豬安全性及有效性的臨牀試驗資格後,新增開展獸用生物製品寵物類、牛安全性及有效性的臨牀試驗資格,為公司新產品研發的快速推進奠定了基礎和保障;同時,標誌着公司獸藥規範化創新與評價能力邁上新台階,將進一步提高公司的研發實力和核心競爭力,對公司實施多元化發展戰略產生促進作用。未來,公司將持續推進獸藥GCP建設,進一步規範獸藥臨牀試驗過程,提高獸藥臨牀試驗質量,提升獸用生物製品的科研水平,為我國動物健康可持續發展保駕護航。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.